Network pharmacology analysis and in vitro verification of the anti-sarcopenia effects of formononetin

Abstract

Sarcopenia (SP) associated with functional impairment is highly prevalent; however, therapeutic strategies addressing this condition remain limited. Inflammation and oxidative stress are the key contributors. Suitably, formononetin (FMN) offers diverse benefits, including antioxidant, anti-apoptotic, and anti-inflammatory properties. Therefore, this study used network pharmacology to identify 81 potential target genes for FMN to alleviate SP. Serine/threonine-protein kinase 1 (AKT1), epidermal growth factor receptor (EGFR), and sirtuin 1 (SIRT1) as the core targets. Kyoto Encyclopedia of Genes and Genome analysis indicated that FMN primarily affects SP via the interleukin (IL)-17, PI3K-Akt and FoxO signalling pathways. Cell studies revealed that FMN reduces IL-6 release and boosts superoxide dismutase activity, thereby enhancing C2C12 skeletal muscle cell vitality. FMN intervention also enhanced AKT1 and SIRT1 gene and protein expression, decreased muscle-specific RING finger protein-1 gene expression, and increased EGFR protein expression. This suggests its anti-inflammatory and antioxidant effects in dexamethasone-treated C2C12 cells, potentially preventing muscle atrophy by inhibiting protein breakdown. These findings highlight the promising multi-target role and molecular mechanism of FMN in the treatment of SP and suggest future clinical applications.

Keywords

Sarcopenia / Formononetin / Network pharmacology / C2C12 cells / Antioxidant / Molecular mechanism

References

[1] Caballero-García A, Pascual-Fernández J, Noriega-González DC, Bello HJ, Pons-Biescas A, Roche E, Córdova-Martínez A. L-citrulline supplementation and exercise in the management of sarcopenia. Nutrients, 2021, 13(9): 3133

[2] Ceyhan AB, Ozcan M, Kim W, Li X, Altay O, Zhang C, Mardinoglu A. Novel drug targets and molecular mechanisms for sarcopenia based on systems biology. Biomed Pharmacother, 2024, 176 116920

[3] Chalkiadaki A, Igarashi M, Nasamu AS, Knezevic J, Guarente L. Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy. PLoS Genet, 2014, 10(7 e1004490

[4] Chang JS, Kong ID. Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes. Pflugers Arch, 2020, 472(4495-502

[5] Chang C, Jia R, Fang B, Miao Y, Zhang L. Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer. Open Med, 2025, 20(1 20241079

[6] Chen C, Yang JS, Lu CC, Chiu YJ, Chen HC, Chung MI, Wu YT, Chen FA. Effect of Quercetin on Dexamethasone-induced C2C12 skeletal muscle cell injury. Molecules, 2020, 25(14): 3267

[7] Chen X, Wang Y, Liu M, Song X, Wang D, Zhang J. Network pharmacology-based analysis of the effects of puerarin on sarcopenia. Ann Transl Med, 2022, 10(12671

[8] Chen C, Hu S, Zhu L, Yao L, Wang X, Zhang A, Zhang Q, Qin L, Wu J. Isolation and identification of chemical constituents of Rubi Fructus, screening novel cannabinoid CB2 receptor agonist and evaluation of its anti-osteoporosis effect. Chin Tradit Herb Drugs, 2024, 55(2386-401

[9] Chen Z, Hu D, Wu C, Wu Z, Lin J, Liu W. ATF3 as a molecular nexus linking ferroptosis regulation to sarcopenia pathogenesis via PI3K/Akt pathway activation. Exp Gerontol, 2025, 209 112830

[10] Chung JY, Kim SG, Kim SH, Park CH. Sarcopenia: how to determine and manage. Knee Surg Relat Res, 2025, 37(1): 12

[11] Domi E, Hoxha M, Prendi E, Zappacosta B. A systematic review on the role of SIRT1 in Duchenne muscular dystrophy. Cells, 2021, 10(61380

[12] Dong Y, Xi Y, Wang Y, Chai Z. Association between sarcopenia and frailty in middle-aged and elder population: findings from the China health and retirement longitudinal study. J Glob Health, 2024, 14: 04163

[13] El-Bakoush A, Olajide OA. Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia. Int Immunopharmacol, 2018, 61: 325-337

[14] Endo T, Akai K, Kijima T, Kitahara S, Abe T, Takeda M, Nabika T, Yano S, Isomura M. An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: a cross-sectional analysis. PLoS ONE, 2021, 16(7 e0252784

[15] Gardner S, Anguiano M, Rotwein P. Defining Akt actions in muscle differentiation. Am J Physiol Cell Physiol, 2012, 303(12C1292-C1300

[16] Ge J, Qian Q, Gao Y, Zhang Y, Li Y, Wang X, Fu Y, Ma Y, Wang Q. Toxic effects of Tripterygium glycoside tablets on the reproductive system of male rats by metabolomics, cytotoxicity, and molecular docking. Phytomedicine, 2023, 114 154813

[17] Girón MD, Vílchez JD, Shreeram S, Salto R, Manzano M, Cabrera E, Campos N, Edens NK, Rueda R, López-Pedrosa JM. Β-hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle. PLoS ONE, 2015, 10(2 e0117520

[18] Guedes IA, de Magalhães CS, Dardenne LE. Receptor-ligand molecular docking. Biophys Rev, 2014, 6(1): 75-87

[19] Hori YS, Kuno A, Hosoda R, Tanno M, Miura T, Shimamoto K, Horio Y. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther, 2011, 338(3): 784-794

[20] Huang Z, Liu Y, Huang X. Formononetin may protect aged hearts from ischemia/reperfusion damage by enhancing autophagic degradation. Mol Med Rep, 2018, 18(6): 4821-4830

[21] Joshi CP, Baldi A, Kumar N, Pradhan J. Harnessing network pharmacology in drug discovery: an integrated approach. Naunyn Schmiedebergs Arch Pharmacol, 2025, 398(5): 4689-4703

[22] Kim TN, Choi KM. Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab, 2013, 20(1): 1-10

[23] Kim Y, Kim CS, Joe Y, Chung HT, Ha TY, Yu R. Quercetin reduces tumor necrosis factor alpha-induced muscle atrophy by upregulation of heme oxygenase-1. J Med Food, 2018, 21(6): 551-559

[24] Kim JY, Kim HM, Kim JH, Guo S, Lee DH, Lim GM, Kim W, Kim CY. Salvia plebeia R.Br. and rosmarinic acid attenuate dexamethasone-induced muscle atrophy in C2C12 myotubes. Int J Mol Sci, 2023, 24(3 1876

[25] Lai Y, Ramírez-Pardo I, Isern J, An J, Perdiguero E, Serrano AL, Li J, García-Domínguez E, Segalés J, Guo P, Lukesova V, Andrés E, Zuo J, Yuan Y, Liu C, Viña J, Doménech-Fernández J, Gómez-Cabrera MC, Song Y, Liu L, Xu X, Muñoz-Cánoves P, Esteban MA. Multimodal cell atlas of the ageing human skeletal muscle. Nature, 2024, 629(8010): 154-164

[26] Le NH, Kim CS, Park T, Park JH, Sung MK, Lee DG, Hong SM, Choe SY, Goto T, Kawada T, Yu R. Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy. Mediat Inflamm, 2014, 2014 834294

[27] Lee D, Goldberg AL. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J Biol Chem, 2013, 288(42): 30515-30526

[28] Lee MK, Choi JW, Choi YH, Nam TJ. Pyropia yezoensis protein prevents dexamethasone-induced myotube atrophy in C2C12 myotubes. Mar Drugs, 2018, 16(12 497

[29] Lee MK, Jeong HH, Kim MJ, Ryu H, Baek J, Lee B. Nutrients against glucocorticoid-induced muscle atrophy. Foods, 2022, 11(5 687

[30] Li Y, Li Z, Ye T, Hao F, Wang Y, Li W, Yan Q, Shi H, Han W. Mechanism of Erzhiwan in treating osteoporosis based on molecular docking technology and molecular dynamics simulation. J Mol Model, 2022, 29(1 21

[31] Liang C, Zhou A, Sui C, Huang Z. The effect of formononetin on the proliferation and migration of human umbilical vein endothelial cells and its mechanism. Biomed Pharmacother, 2019, 111: 86-90

[32] Liao Z, Chen J, Xiao M, Sun Y, Zhao Y, Pu D, Lv A, Wang M, Zhou J, Zhu S, Zhao K, Xiao Q. The effect of exercise, resveratrol or their combination on sarcopenia in aged rats via regulation of AMPK/Sirt1 pathway. Exp Gerontol, 2017, 98: 177-183

[33] Liu L, Hu R, You H, Li J, Liu Y, Li Q, Wu X, Huang J, Cai X, Wang M, Wei L. Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease. J Cell Mol Med, 2021, 25(3): 1493-1506

[34] Liu K, Cao Z, Huang S, Kong F. Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis. BMC Complement Med Ther, 2023, 23(1): 405

[35] Liu H, Yuan S, Zheng K, Liu G, Li J, Ye B, Yin L, Li Y. IL-17 signaling pathway: a potential therapeutic target for reducing skeletal muscle inflammation. Cytokine, 2024, 181 156691

[36] Liu SY, Chen LK, Jhong YT, Chen CW, Hsiao LE, Ku HC, Lee PH, Hwang GS, Juan CC. Endothelin-1 impairs skeletal muscle myogenesis and development via ETB receptors and p38 MAPK signaling pathway. Clin Sci, 2024, 138(12711-723

[37] Liu Z, Huang H, Yu Y, Jia Y, Li L, Shi X, Wang F. Exploring the potential molecular mechanism of the shugan jieyu capsule in the treatment of depression through network pharmacology, molecular docking, and molecular dynamics simulation. Curr Comput Aided Drug des, 2024, 20(5): 501-517

[38] Long L, Tang X, Wang Y, Gu J, Xiong J, Luo H, Lv H, Zhou F, Cao K, Lin S. Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of luteolin against chondrocyte senescence. Comb Chem High Throughput Screen, 2025, 28(2): 291-305

[39] Lou C, Deng A, Zheng H, Sun G, Zhao H, Li A, Liu Q, Li Y, Lv Z. Pinitol suppresses TNF-α-induced chondrocyte senescence. Cytokine, 2020, 130 155047

[40] Luo L, Fan M, Zhao H, Li M, Wu X, Gao W. Pharmacokinetics and bioavailability of the isoflavones formononetin and ononin and their in vitro absorption in Ussing chamber and Caco-2 cell models. J Agric Food Chem, 2018, 66(11): 2917-2924

[41] Lv Y, Hu W, Wang Y, Huang L, He Y, Xie X. Identification and determination of flavonoids in astragali radix by high performance liquid chromatography coupled with DAD and ESI-MS detection. Molecules, 2011, 16(3): 2293-2303

[42] Ma X, Wang J. Formononetin: a pathway to protect neurons. Front Integr Neurosci, 2022, 16 908378

[43] Ma J, Yu P, Ma S, Li J, Wang Z, Hu K, Su X, Zhang B, Cheng S, Wang S. Bioinformatics and integrative experimental method to identifying and validating co-expressed ferroptosis-related genes in OA articular cartilage and synovium. J Inflamm Res, 2024, 17: 957-980

[44] Machado Dutra J, Espitia PJP, Andrade Batista R. Formononetin: biological effects and uses - a review. Food Chem, 2021, 359 129975

[45] Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int, 2016, 98(4): 319-333

[46] Muraki I. Muscle mass assessment in sarcopenia: a narrative review. JMA J, 2023, 6(4): 381-386

[47] Okpako IO, Ng'ong'a FA, Kyama CM, Njeru SN. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complement Med Ther, 2024, 24(1): 338

[48] Ong SKL, Shanmugam MK, Fan L, Fraser SE, Arfuso F, Ahn KS, Sethi G, Bishayee A. Focus on formononetin: anticancer potential and molecular targets. Cancers, 2019, 11(5611

[49] Onishi T, Sakai H, Uno H, Sakakibara I, Uezumi A, Honda M, Kai T, Higashiyama S, Miura N, Kikugawa T, Saika T, Imai Y. Epidermal growth factor receptor contributes to indirect regulation of skeletal muscle mass by androgen. Endocr J, 2025, 72(3259-272

[50] Otsuka Y, Egawa K, Kanzaki N, Izumo T, Rogi T, Shibata H. Quercetin glycosides prevent dexamethasone-induced muscle atrophy in mice. Biochem Biophys Rep, 2019, 18100618

[51] Park SY, Patnaik BB, Kang SW, Hwang HJ, Chung JM, Song DK, Sang MK, Patnaik HH, Lee JB, Noh MY, Kim C, Kim S, Park HS, Lee JS, Han YS, Lee YS. Transcriptomic analysis of the endangered neritid species Clithon retropictus: de novo assembly, functional annotation, and marker discovery. Genes, 2016, 7(7 35

[52] Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem, 2015, 58(9): 4066-4072

[53] Qian X, Zhang L, Xie F, Cheng Y, Cui D. Network-based pharmacological study on the mechanism of Guishao-Liujun decoction in the treatment of gastric cancer. Front Pharmacol, 2022, 13 937439

[54] Schakman O, Gilson H, Kalista S, Thissen JP. Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res, 2009, 72(Suppl 1): 36-41

[55] Seo E, Truong CS, Jun HS. Psoralea corylifolia L. seed extract attenuates dexamethasone-induced muscle atrophy in mice by inhibition of oxidative stress and inflammation. J Ethnopharmacol, 2022, 296 115490

[56] Shameer K, Sowdhamini R. Functional repertoire, molecular pathways and diseases associated with 3D domain swapping in the human proteome. J Clin Bioinforma, 2012, 2(1): 8

[57] Sirago G, Toniolo L, Crea E, Giacomello E. A short-term treatment with resveratrol improves the inflammatory conditions of middle-aged mice skeletal muscles. Int J Food Sci Nutr, 2022, 73(5630-637

[58] Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell, 2004, 14(3): 395-403

[59] Sugimoto M, Ko R, Goshima H, Koike A, Shibano M, Fujimori K. Formononetin attenuates H₂O₂-induced cell death through decreasing ROS level by PI3K/Akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells. Neurotoxicology, 2021, 85: 186-200

[60] Sun M, Zhou T, Zhou L, Chen Q, Yu Y, Yang H, Zhong K, Zhang X, Xu F, Cai S, Yu A, Zhang H, Xiao R, Xiao D, Chui D. Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sAβPPα. J Alzheimers Dis, 2012, 28(4): 795-808

[61] Sun D, Lu Y, Zhang SJ, Wang KG, Sun Z. Research on the effect of formononetin on photodynamic therapy in K562 cells. Gen Physiol Biophys, 2017, 36(4): 423-430

[62] Tay KC, Tan LT, Chan CK. Formononetin: a review of its anticancer potentials and mechanisms. Front Pharmacol, 2019, 10: 820

[63] Teng H, Liu Y, Hao R, Zhang L, Zhang X, Li S, Li S, Tong H. The mechanism of EGF in promoting skeletal muscle post-injury regeneration. Differentiation, 2025, 143 100862

[64] Tseng YT, Chang WH, Lin CC, Chang FR, Wu PC, Lo YC. Protective effects of Liuwei dihuang water extracts on diabetic muscle atrophy. Phytomedicine, 2019, 53: 96-106

[65] Tshiluka NR, Mbedzi DT, Bvumbi MV, Mnyakeni-Moleele SS. In vitro α-glucosidase inhibition, cytotoxicity, SAR, Swiss ADME prediction and molecular docking study of new N-substituted hydantoin derivatives. ChemistryOpen, 2025, 14(4 e202400119

[66] Wang D, Yin Y, Yang Y, Lv P, Shi Y, Lu L, Wei L. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes. Int Immunopharmacol, 2014, 19(2): 206-213

[67] Wang R, Jiao H, Zhao J, Wang X, Lin H. Glucocorticoids enhance muscle proteolysis through a myostatin-dependent pathway at the early stage. PLoS ONE, 2016, 11(5 e0156225

[68] Wang F, Mo CL, Lu M, Deng X, Luo J. Network pharmacology to explore the mechanism of traditional Chinese medicine in the treatment of ground glass nodules. J Thorac Dis, 2024, 16(5): 2745-2756

[69] Wang Y, Wang Y, Zhang M, Liu D, Fang J. Informational analysis and prediction of obsessive-compulsive disorder pathogenesis. Psychiatry Investig, 2024, 21(5): 464-474

[70] Wang Y, Wang J, Chen Z, Liu B, Wang W, Li Y. Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking. Medicine, 2025, 104(6 e40255

[71] Wu Y, Luo J, Xu B. Network pharmacology and bioinformatics to identify the molecular mechanisms of Gleditsiae Spina against colorectal cancer. Curr Res Toxicol, 2023, 5 100139

[72] Xiao J, Zhang P, Cai F, Luo C, Pu T, Pan X, Tian M. IL-17 in osteoarthritis: a narrative review. Open Life Sci, 2023, 18(1 20220747

[73] Xie T, Ren X, Zhuang H, Jiang F, Zhang Y, Zhou P. Down-regulation of Jun induces senescence through destabilizing chromatin in osteoarthritis chondrocytes. Am J Transl Res, 2023, 15(7): 4873-4886

[74] Xue Q, Liu X, Russell P, Li J, Pan W, Fu J, Zhang A. Evaluation of the binding performance of flavonoids to estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock. Ecotoxicol Environ Saf, 2022, 233 113323

[75] Yang H, Shi L, Shi G, Guo Y, Chen D, Chen D, Shi J. Connexin 43 affects osteogenic differentiation of the posterior longitudinal ligament cells via regulation of ERK activity by stabilizing Runx2 in ossification. Cell Physiol Biochem, 2016, 38(1): 237-247

[76] Yang X, Li L, Xue Y, Zhou X, Tang J. Flavonoids from Epimedium pubescens: extraction and mechanism, antioxidant capacity and effects on CAT and GSH-Px of Drosophila melanogaster. PeerJ, 2020, 8 e8361

[77] Yang Y, Wei Q, An R, Zhang H, Shen J, Qin X, Han X, Li J, Li X, Gao X, He J, Mao H. Anti-osteoporosis effect of Semen Cuscutae in ovariectomized mice through inhibition of bone resorption by osteoclasts. J Ethnopharmacol, 2022, 285 114834

[78] Zeng Q, Zhao L, Zhong Q, An Z, Li S. Changes in sarcopenia and incident cardiovascular disease in prospective cohorts. BMC Med, 2024, 22(1): 607

[79] Zhang C, Li Y, Wu Y, Wang L, Wang X, Du J. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem, 2013, 288(31489-1499

[80] Zhang F, Yan Y, Cai Y, Liang Q, Liu Y, Peng B, Xu Z, Liu W. Current insights into the functional roles of ferroptosis in musculoskeletal diseases and therapeutic implications. Front Cell Dev Biol, 2023, 11: 1112751

[81] Zhang X, Ji C, Fu Y, Yang Y, Xu G. Screening of active components of Ganoderma lucidum and decipher its molecular mechanism to improve learning and memory disorders. Biosci Rep, 2024, 44(7 BSR20232068

[82] Zhao Y, Jiang Q, Zhang X, Zhu X, Dong X, Shen L, Zhang S, Niu L, Chen L, Zhang M, Jiang J, Chen D, Zhu L. L-arginine alleviates LPS-induced oxidative stress and apoptosis via activating SIRT1-AKT-Nrf2 and SIRT1-FOXO3a signaling pathways in C2C12 myotube cells. Antioxidants, 2021, 10(12 1957

[83] Zhao J, Lin F, Liang G, Han Y, Xu N, Pan J, Luo M, Yang W, Zeng L. Exploration of the molecular mechanism of Polygonati Rhizoma in the treatment of osteoporosis based on network pharmacology and molecular docking. Front Endocrinol, 2022, 12 815891

[84] Zhou C, Ma H, Liu C, Yang L. Exploring traditional Chinese medicine as a potential treatment for sarcopenia: a network pharmacology and data mining analysis of drug selection and efficacy. Medicine, 2023, 102(41 e35404

RIGHTS & PERMISSIONS

The Author(s)